These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 207230)

  • 21. Influence of age on induction of mammary tumors by diethylstilbestrol in C3H/HeN mice with low murine mammary tumor virus titer.
    Greenman DL; Highman B; Chen JJ; Schieferstein GJ; Norvell MJ
    J Natl Cancer Inst; 1986 Oct; 77(4):891-8. PubMed ID: 3020299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A new antibiotic with antineoplastic activity: rubidomycin (13.057 R.P.). II. Experimental antitumor activity].
    Maral R; Bourat G; Fournel J; Ganter P; de Ratuld Y; Werner GH
    Arzneimittelforschung; 1967 Aug; 17(8):939-48. PubMed ID: 4299568
    [No Abstract]   [Full Text] [Related]  

  • 23. Mammary tumor virus oncogenesis and tumor immunogenicity in three sublines of the C3H mouse.
    Vaage J; Medina D
    Cancer Res; 1978 Aug; 38(8):2443-7. PubMed ID: 208767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative immunotherapeutic effect of concanavalin A and neuraminidase-treated cancer cells.
    Simmons RL; Rios A
    Transplant Proc; 1975 Jun; 7(2):247-51. PubMed ID: 1129845
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison of the chemosensitivity of murine tumours in vivo and in cell culture.
    Bullen BR; Russell CW; Giles GR
    Clin Oncol; 1978 Sep; 4(3):265-72. PubMed ID: 750129
    [No Abstract]   [Full Text] [Related]  

  • 26. Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.
    Corbett TH; Griswold DP; Mayo JG; Laster WR; Schabel FM
    Cancer Res; 1975 Jun; 35(6):1568-73. PubMed ID: 1131824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partial regression, yet incomplete eradication of mammary tumors in transgenic mice by retrovirally mediated HSVtk transfer 'in vivo'.
    Sacco MG; Benedetti S; Duflot-Dancer A; Mesnil M; Bagnasco L; Strina D; Fasolo V; Villa A; Macchi P; Faranda S; Vezzoni P; Finocchiaro G
    Gene Ther; 1996 Dec; 3(12):1151-6. PubMed ID: 8986442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Approaches to combination chemotherapy in rat, mouse, and hamster tumors.
    Griswold DP; Dykes DJ; Kelley CA; Roberts BJ; Dominick CA
    Cancer Chemother Rep 2; 1974 Mar; 4(1):99-108. PubMed ID: 4524043
    [No Abstract]   [Full Text] [Related]  

  • 29. [Changes in the properties of mammary factor carcinomas of C3H strain mice treated with exogenous RNA].
    Tomsons VP; Pyrinova GB
    Dokl Akad Nauk SSSR; 1980; 251(4):987-91. PubMed ID: 6156814
    [No Abstract]   [Full Text] [Related]  

  • 30. Remissions of mammary adenocarcinoma in hypothyroid mice given 5-fluorouracil and chloroquine phosphate.
    Shoemaker JP; Dagher RK
    J Natl Cancer Inst; 1979 Jun; 62(6):1575-8. PubMed ID: 286128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biology and therapeutic response of a mouse mammary adenocarcinoma (16/C) and its potential as a model for surgical adjuvant chemotherapy.
    Corbett TH; Griswold DP; Roberts BJ; Peckham JC; Schabel FM
    Cancer Treat Rep; 1978 Oct; 62(10):1471-88. PubMed ID: 709550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The antitumor effect of certain aromatic ketoaldehydes].
    Picotti GB; Testorelli C
    Arch Ital Patol Clin Tumori; 1968; 11(3):465-74. PubMed ID: 5737816
    [No Abstract]   [Full Text] [Related]  

  • 33. Viruses and breast cancer: implications of mouse and human studies.
    Borden EC
    Johns Hopkins Med J; 1974 Feb; 134(2):66-76. PubMed ID: 4129845
    [No Abstract]   [Full Text] [Related]  

  • 34. [Change in the weight of certain lymphoid organs as a criterion of the toxic action of antitumor preparations].
    Maliugina LL; Pol'kina RI
    Vopr Onkol; 1974; 20(3):62-9. PubMed ID: 4439803
    [No Abstract]   [Full Text] [Related]  

  • 35. Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XLI. Plant extracts.
    Abbott BJ; Hartwell JL; Leiter J; Spetzman LA; Schepartz SA
    Cancer Res; 1967 May; 27(5 Pt 2):364-527. PubMed ID: 4290629
    [No Abstract]   [Full Text] [Related]  

  • 36. Combination heparin plus cortisone treatment of two transplanted tumors in C3H/He mice.
    Penhaligon M; Camplejohn RS
    J Natl Cancer Inst; 1985 Apr; 74(4):869-73. PubMed ID: 3857381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunology of the mouse mammary tumor virus: comparison of mammary tumor virus with the agent found in C3Hf/Crgl mice.
    Blair PB; Weiss DW
    J Natl Cancer Inst; 1966 Mar; 36(3):423-9. PubMed ID: 18630318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Inhibition of tumor cell growth using lectin from the bean of Ricinus communis].
    Gürtler L; Steinhoff D
    Hoppe Seylers Z Physiol Chem; 1972 Oct; 353(10):1521. PubMed ID: 4649787
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of tumor growth by metyrapone and desoxycorticosterone.
    Rettura G; Sarkar D; Padawer J; Levenson SM; Seifter E
    Surg Forum; 1976; 27(62):153-4. PubMed ID: 1019837
    [No Abstract]   [Full Text] [Related]  

  • 40. Biophysical aspects of the integrated combination of cytostatic drugs with radiotherapy. Part 3: In vivo investigations on murine C3H mammary adenocarcinoma treated with cis-platinum, adriamycin, epirubicin, activated cyclophosphamide, activated isophosphamide and irradiation with 10 MeV electrons--verification of the therapeutic results with 31P-NMR spectroscopy.
    Ulmer W
    Strahlenther Onkol; 1991 Sep; 167(9):553-60. PubMed ID: 1925940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.